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Our previous studies showed that adult (8 month) mice lacking CuZn-superoxide dismutase (CuZnSOD,
Sod1KO mice) have neuromuscular changes resulting in dramatic accelerated muscle atrophy and
weakness that mimics age-related sarcopenia. We have further shown that loss of CuZnSOD targeted to
skeletal muscle alone results in only mild weakness and no muscle atrophy. In this study, we targeted
deletion of CuZnSOD speciﬁcally to neurons (nSod1KO mice) and determined the effect on muscle mass
and weakness. The nSod1KO mice show a signiﬁcant loss of CuZnSOD activity and protein level in brain
and spinal cord but not in muscle tissue. The masses of the gastrocnemius, tibialis anterior and extensor
digitorum longus (EDL) muscles were not reduced in nSod1KO compared to wild type mice, even at
20 months of age, although the quadriceps and soleus muscles showed small but statistically signiﬁcant
reductions in mass in the nSod1KO mice. Maximum isometric speciﬁc force was reduced by 8–10% in the
gastrocnemius and EDL muscle of nSod1KO mice, while soleus was not affected. Muscle mitochondrial
ROS generation and oxidative stress measured by levels of reactive oxygen/nitrogen species (RONS)
regulatory enzymes, protein nitration and F2-isoprostane levels were not increased in muscle from the
nSod1KO mice. Although we did not ﬁnd evidence of denervation in the nSod1KO mice, neuromuscular
junction morphology was altered and the expression of genes associated with denervation acetylcholine
receptor subunit alpha (AChRα), the transcription factor, Runx1 and GADD45α) was increased, sup-
porting a role for neuronal loss of CuZnSOD initiating alterations at the neuromuscular junction. These
results and our previous studies support the concept that CuZnSOD deﬁcits in either the motor neuron or
muscle alone are not sufﬁcient to initiate a full sarcopenic phenotype and that deﬁcits in both tissues are
required to recapitulate the loss of muscle observed in Sod1KO mice.
Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Our previous studies have provided signiﬁcant insight into
potential mechanisms of sarcopenia using mice that lack CuZn-
superoxide dismutase (CuZnSOD), i.e., Sod1KO mice, as a model ofaccess article under the CC BY-NC
ing Research Program, Okla-
et, Oklahoma City, OK 73104,
an Remmen).age-related muscle atrophy. Although indistinguishable from wild
type mice at birth, by 5–8 months of age, gastrocnemius muscles
of Sod1KO mice display signiﬁcant reductions in mass and function
that progress through adulthood, such that by 20 months of age
Sod1KO mice resemble 30-month-old wild type mice [1–3]. In
addition, both Sod1KO mice and old wild type mice exhibit pro-
found alterations in neuromuscular innervation in conjunction
with the initiation of skeletal muscle atrophy [2]. Post-synaptic
endplates are severely disrupted, the number of acetylcholine
receptors (AChRs) is reduced and the receptors are signiﬁcantly
fragmented. Finally, mitochondrial function is reduced and-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
K. Sataranatarajan et al. / Redox Biology 5 (2015) 140–148 141mitochondrial ROS generation is elevated in both adult Sod1KO
mice and old wild type mice. Overall, our ﬁndings in the Sod1KO
mice point to the signiﬁcance of neuromuscular interaction in
maintenance of mitochondrial function and muscle mass and
suggest that disruption of the neuromuscular junction (NMJ)
might be a trigger for decline in muscle mass and function during
aging.
Because muscle and motor neurons are integrally related by
structure and function, the question has always arisen as to the
relative roles of these two tissues in the mechanism responsible
for muscle atrophy. Similar questions have been raised in the ﬁeld
of ALS and other neuromuscular diseases in which muscle atrophy
and weakness are a predominant phenotype. The observation that
Sod1KO mice replicate the sarcopenia phenotype observed in old
wild type mice provides us with the ability to use genetic
approaches to dissect out the role of the motor neuron and muscle
in sarcopenia and to begin identifying key pathways in these tis-
sues that are critical in the loss of muscle mass and function. Our
ﬁrst study showed that replacing CuZnSOD speciﬁcally in the
motor neurons in Sod1KO mice (nSod1-Tg/Sod1KO mice) prevented
muscle atrophy and weakness, as well as the NMJ degeneration
associated with loss of mass and function. These data suggested
that motor neuron deﬁcits resulting from oxidized redox status are
a key initiating event in sarcopenia in the Sod1KO mice [4]. In
contrast, deleting Sod1 speciﬁcally in skeletal muscle (mSod1KO
mice) had no effect on either muscle atrophy or NMJ degeneration
[5], demonstrating that loss of Sod1 in muscle alone is not sufﬁ-
cient to generate atrophy. Based on our experiments with the
nSod1-Tg/Sod1KO and mSod1KO mice, we speculated that the loss
of Sod1 in the motor neuronwas the critical feature contributing to
the sarcopenia observed in the whole body Sod1KO mice. Thus, we
hypothesized that neuronal speciﬁc Sod1KO (nSod1KO) mice
would recapitulate the phenotype of the Sod1KO mice. To test this
hypothesis, we generated a neuronal speciﬁc knockout mice using
our Sod1-ﬂoxed mice crossed to transgenic mice expressing Cre
recombinase driven by the nestin promoter (nestin-Cre transgenic
mice) and compared nSod1KO and wild type mice for muscle
atrophy and weakness, as well as a number of parameters that we
had previously measured in the Sod1KO mice, including muscle
properties such as ﬁber diameter and myonuclear domain, oxi-
dative stress and markers of altered redox, changes in acetyl
choline receptor morphology and markers of denervation. Con-
trary to our hypothesis, our results show that loss of neuronal
CuZnSOD was not sufﬁcient to induce muscle atrophy and weak-
ness that is observed in the Sod1KO mice.Materials and methods
Generation of neuron-speciﬁc Sod1-knockout (nSod1KO) mice
Details of the generation of the Sod1ﬂox/ﬂox mice was reported
in our earlier publication [5]. To generate nSod1KO mice,
Sod1ﬂox/ﬂox mice were bred with a mouse strain that expresses Cre
recombinase under the control of the nestin promoter [(B6.Cg
(SJL)-Tg(Nes-cre)1Kln/J)] that we obtained from Jackson laboratory
(Bar Harbor, ME, USA). Mice were maintained on a 12-h dark/light
cycle and provided with food and water ad libitum. At sacriﬁce,
mice were euthanized by CO2 inhalation and tissues were imme-
diately excised and weighed. All the tissues, except those used for
immunostaining, were snap frozen and stored at 80 °C. All ani-
mal protocols were consistent with The Guide for the Care and Use
of Laboratory Animals and approved by the Institutional Animal
Care and Use Committee at Oklahoma Medical Research Founda-
tion (OKC, OK, USA).Measurement of CuZnSOD and MnSOD activity
CuZnSOD and MnSOD activity in brain, spinal cord and muscles
were determined using native gels as described [7].
CuZnSOD immunoblot analysis
Equal amounts of protein from brain, spinal cord, gastro-
cnemius and quadriceps muscle were resolved by SDS-PAGE and
transferred to PVDF membrane. The membranes were blocked and
probed with CuZnSOD (Enzo Life Sciences, Inc., Farmingdale, NY,
USA) and GAPDH (Sigma, St. Louis, MO, USA) antibodies overnight
at 4 °C. Membranes were washed extensively and incubated with
secondary antibodies linked to horseradish peroxidase (Santa Cruz
Biotechnology, Dallas, TX, USA). Proteins were visualized using
enhanced chemiluminescence reagent and signal intensities were
quantiﬁed using ImageJ 1.45b software (developed by Wayne
Rasband, National Institute of Health, Bethesda, MD).
Western blotting of RONS proteins in skeletal muscle
Muscles were ground in a motor and pestle under liquid
nitrogen and frozen muscle powder was placed into RIPA buffer
containing 50 mM Tris (pH 7.4), 150 mM NaCl, and protease inhi-
bitors. Samples were homogenized on ice and centrifuged at
10,000g for 10 min at 4 °C. Protein content of samples was deter-
mined using the bicinchoninic acid method (Sigma-Aldrich, Poole,
UK). For assessment of speciﬁc proteins in muscle, 20 mg of total
protein was applied to a 4–20% mini-PROTEAN TGX precast gel
with a 4% stacking gel (Biorad Laboratories Ltd., Hemel Hemp-
stead, UK). The separated proteins were transferred onto nitro-
cellulose membranes by western blotting. Membranes were pro-
bed using antibodies against MnSOD (SOD2), (Stressgen Inc., UK),
eNOS, iNOS, PRXV, and GAPDH (Abcam, Cambridge, UK). Horse-
radish peroxidase conjugated anti-rabbit IgG or anti-mouse IgG
(Cell Signalling, Hitchin, UK) was used as secondary antibody.
Peroxidase activity was detected using an ECL Plus substrate
(Amersham International Cardiff, UK), and band intensities were
analyzed using Quantity One Software (Biorad Laboratories Ltd.,
Hemel Hempstead, UK). The speciﬁcity of the bands was identiﬁed
in comparison with a sample that had not been exposed to the
primary antibody and the molecular weight was determined by
using molecular weight markers. All protein contents were nor-
malized to the GAPDH content of the same sample.
Analysis of the 3-nitrotyrosine (3-NT) content of muscle proteins
Total cellular protein was isolated and 20 mg was separated by
SDS-PAGE followed by western blotting as describe above. The
separated proteins were transferred onto polyvinylidene diﬂuoride
(PVDF) membranes. The content of 3-NT was analyzed by using a
rabbit monoclonal antibody (Cell Biolabs, San Diego, USA), as per
the manufacturer’s instructions. Bands were visualized and den-
sitometric quantiﬁcation was undertaken using Quantity One
Software (Biorad Laboratories., Hemel Hempstead, UK).
Analysis of F2-isoprostanes
Levels of F2-isoprostanes in quadriceps muscle was measured
as described [6,8]. Brieﬂy, 200 mg of tissue was homogenized in
10 ml of ice-cold Folch solution (CHCl3:MeOH, 2:1) containing
butylated hydroxytoluene (BHT). The mixture was incubated at
room temperature for 30 min. 2 ml of 0.9% NaCl was added and
mixed well. The homogenate was centrifuged at 3000g for 5 min
at 4 °C. The aqueous layer was discarded while the organic layer
was secured and evaporated to dryness under N2 at 37 °C.
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graphy–mass spectrometry. The level of F2-isoprostanes in muscle
tissues was expressed as nanograms of 8-Iso-PGF2α, per gram of
muscle tissue.
Real-time PCR
Total RNA was extracted from the gastrocnemius and quad-
riceps of the wild type and nSod1KO mice using TRI reagent (Life
Technologies, Grand Island, NY, USA). RNA purity and yield were
determined by measuring the absorbance at 260 and 280 nm.
cDNA was prepared from 1 mg of the total RNA using iScriptTM
cDNA Synthesis kit (Bio-Rad, Hercules, CA, USA). 2.5 ng of cDNA
samples were ampliﬁed using primers for AChRα, Musk, Rapsyn,
Runx1, GADD45α and 18S along with fast SYBR green master mix
(Applied Biosystems, Grand Island, NY, USA). The data were ana-
lyzed using the ΔΔCt method.
Contractile force
Mice were anesthetized by intraperitoneal injection of Avertin
(tribromoethanol, 250 mg/kg) supplemented to maintain an ade-
quate level of anesthesia during all procedures. Gastrocnemius
muscle contractile properties were measured in situ, as described
by Larkin et al. [3]. Anesthetized mice were placed on a platform
warmed to maintain body temperature at 37 °C. The gastro-
cnemius muscle was isolated from surrounding tissues and the
distal tendon was securely tied to the lever arm of a servomotor
(model 6650LR, Cambridge Technology). The knee and foot were
clamped to the platform. A continual drip of saline warmed to
37 °C was applied to the gastrocnemius muscle to maintain its
temperature. The muscle was activated by stimulation of the tibial
nerve. With the muscle held at optimal length (Lo), 300-ms trains
of stimulus pulses were applied at increasing stimulation fre-
quencies until the maximum isometric tetanic force (Po) was
achieved. Contractile properties were measured for extensor
digitorum longus and soleus muscles in vitro as described by
Brooks and Faulkner [9]. Muscles were placed in a horizontal bath
containing buffered mammalian Ringer solution maintained at
25 °C and tied to a force transducer (model BG-50, Kulite Semi-
conductor Products, Leonia, NJ) and a servomotor (model 305B,
Aurora Scientiﬁc, Aurora, ON). Muscles were stimulated by plati-
num plate electrodes connected to a high-power biphasic current
stimulator (model 701B, Aurora Scientiﬁc). Muscles were held at Lo
and subjected to trains of pulses of 300 ms duration for EDL
muscles and 900 ms for soleus muscles. Stimulus frequency was
increased until the Po was achieved.
After muscles were removed, deeply anesthetized mice were
euthanized by pneumothorax and removal of a vital organ. Mus-
cles were trimmed of their tendons, blotted and weighed. Fiber
lengths (Lf) were estimated by multiplying Lo by previously
determined Lf-to-Lo ratios [3,9], and physiological cross-sectional
areas (CSA) of the muscles were determined by dividing the mass
of the muscle by the product of Lf and 1.06 g/cm3, the density of
mammalian skeletal muscle. The speciﬁc Po was determined by
dividing Po by the physiological CSA.
Neuromuscular junction (NMJ) imaging
For imaging acetylcholine receptors (AchRs), longitudinal
muscle sections were permeabilized with 1% triton X-100 for 1 h
at room temperature and then incubated with Alexa Fluor 647-
conjugated bungarotoxin (Molecular Probes, Eugene, OR, USA)
diluted in PBS and 1% triton X-100 for 1 h at room temperature.
Sections were washed with PBS and mounted in Vectashield(Vector Laboratories, Peterborough, UK). Immune ﬂuorescence
imaging was obtained with a Nikon TE2000U microscope.Analysis of ﬁber diameter, nuclei number and myonuclear domain
Gastrocnemius and quadriceps muscles were dissected,
weighed and immediately placed in relaxing solution at 4 °C
{0.1 M KCl, 0.01 M imidazole (pH 7.0), 1 mM MgCl2, 2 mM EGTA
and 4.5 mM ATP}. The bundles of E50–100 ﬁbers were dissected
in the chilled relaxing solution and chemically skinned in relaxing
solution containing 50% (v/v) glycerol for 24 h at 4 °C and stored at
20 °C for up to 4 weeks before use. On the day of the experi-
ment, single ﬁber segments were gently dissected free from the
bundle and carefully placed on the glass slide. After a brief per-
meabilization with 0.1% Triton X-100, ﬁbers were stained with
rhodamine–phalloidin (1:200, Molecular Probe Inc., Eugene, OR,
USA) for 45 min and DAPI (Invitrogen, Molecular Probes, OR, USA)
for 5 min followed by ﬁnal washes. Linear ﬁber segments of
E350–450 mmwere chosen for imaging. All images were captured
with a Nikon TE2000U inverted ﬂuorescence microscope equipped
with a 20 phase-contrast objective (NA 0.45) and imported into
ImageJ software (developed by Wayne Rasband, National Institute
of Health, Bethesda, MD) for analysis.MyHC isoforms composition by gel electrophoresis
In short, the myosin heavy chain (MyHC) isoform composition
of the muscle was determined by SDS-PAGE as previously descri-
bed [10]. The total acrylamide and bis concentration were 4% (w/v)
in the stacking gel and 8% in the running gel, and the gel matrix
included 30% glycerol. Sample loads were kept small to improve
the resolution of the MyHC bands, and the electrophoresis was
performed at 120 V for 24 h with a Tris–glycine electrode buffer
(pH¼8.3) at 4 °C.Mitochondrial H2O2 generation
Intact isolated mitochondria from the gastrocnemius muscles
were used to measure reactive oxygen species (ROS) generation
indirectly as H2O2 release using the ﬂuorescent probe Amplex Red
(Molecular Probes, Eugene, OR, USA) as described previously [1,5].
The assay was performed in 100 ml of reaction buffer that con-
tained 125 mM KCl, 10 mM HEPES, 5 mM MgCl2, and 2 mM
K2HPO4 (pH 7.44) along 20–50 mg of mitochondrial protein with
and without respiratory substrates GM (2.5 mM glutamate and
2.5 mM malate) at 37 °C. Amplex Red oxidation by H2O2 every 2 s
for 10 min at an excitation of 545 nm and an emission of 590 nm
was measured using a Fluoroskan-FL Ascent Type 374 multiwell
plate reader (Labsystems, Helsinki, Finland).Statistical analysis
Data are presented as mean7SEM or SD for each experiment
as detailed in the ﬁgure legends. Comparisons among the three
groups were performed by analysis of variance (ANOVA) while
Student’s t-test was performed to compare 2 groups. Data were
analyzed using SPSS 22 or Prism 6 and p values of less than 0.05
were considered statistically signiﬁcant.
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Generation and characterization of a conditional mouse model with
reduced CuZnSOD targeted to neuronal tissue
NesCre Sod1ﬂox/ﬂox mice (nSod1KO mice) are expected to
show a reduction in CuZnSOD expression in neuronal tissue with
no change in CuZnSOD expression in other tissues (i.e., in muscle).
As shown in Fig. 1, nSod1KO mice show a dramatic reduction in the
activity (A) and protein levels (B) of CuZnSOD in brain and spinal
cord. In contrast, CuZnSOD activity and level in gastrocnemius and
quadriceps muscle from nSod1KOmice are equivalent to the values
measured in wild type mice. Thus, the nSod1KO mice we have
generated shows a neuron speciﬁc loss of CuZnSOD and normal
levels of muscle CuZnSOD, giving us a model to directly test the
role of reduced CuZnSOD in neurons in the loss of muscle mass
and NMJ disaggregation that is observed in Sod1KO mice.
Effect of neuronal depletion of CuZnSOD on muscle mass and strength
Our previous studies showed that Sod1KO mice have signiﬁcant
muscle atrophy in a number of muscles. For example, the mass of
lower hind limb muscles, in particular the gastrocnemius muscle, a
muscle that undergoes a signiﬁcant loss of mass during aging [1,3],
is reduced by 30%–45% by 20 months of age [1,3,11]. We have also
reported that muscle strength, as measured by speciﬁc force, is
reduced in Sod1KO mice approximately by 50% at 8 month of age
[3]. We measured muscle mass in a number of individual hind
limb muscles in 17- to 20-month-old wild type and nSod1KO mice.
As shown in Fig. 2A, mass was not altered in the gastrocnemius,
tibialis anterior (data not shown) or extensor digitorum longus
muscles, while quadriceps (14%) and soleus muscles (less than
10%) showed small but signiﬁcant reductions in mass. Muscle-
speciﬁc effects were also evident in measures of contractile force
(Fig. 2B). Despite no change in mass, both the extensor digitorumGastrocnemius
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Fig. 1. Generation of neuron-speciﬁc Sod1-knockout (nSod1KO) mice. (A) Native gels stai
and spinal cord of wild type and nSod1KO mice. (B) Western blot analysis of CuZnSOD
nSod1KO (n¼3–6 mice in each group between 7 and 18 months of age). Both males anlongus and gastrocnemius showed small but signiﬁcant reductions
(10%) in speciﬁc force. In contrast, the soleus muscle, which
showed a reduction in mass, showed no loss of speciﬁc force
generation.
Changes in muscle properties in gastrocnemius and quadriceps
muscle from wild type and nSod1KO mice
Because the gastrocnemius and quadriceps muscle showed
differential changes in mass in response to the neuronal depletion
of CuZnSOD, we measured a number of additional properties of
these two muscles. We previously reported a signiﬁcant reduction
in ﬁber diameter in gastrocnemius muscle of 20-month-old
Sod1KO mice compared to wild type mice as well as a reduction in
the number of nuclei present per mm of muscle ﬁber [2]. The
myonuclear domain (MND), which is a measure of the cytoplasmic
domain per myonucleus, was not different in wild type and
Sod1KO mice. We measured the ﬁber diameter in a total of 361
muscle ﬁbers from gastrocnemius and quadriceps muscles of wild
type (N¼5, n¼225) and nSod1KO (N¼3, n¼136) mice. In contrast
to muscles of Sod1KO mice, the data in Fig. 3A show there was no
signiﬁcant difference in ﬁber diameter between the two experi-
mental groups in either muscle. We also measured the number of
nuclei per mm of ﬁber length and calculated the size of the MNDs
along the length of single muscle ﬁber linear segments. We found
no difference in the number of nuclei per unit length between the
wild type and nSod1KO mice in either muscle (Fig. 3B). The MND
was not altered in the gastrocnemius muscle, but was slightly
reduced in ﬁbers from the quadriceps muscle from nSod1KO mice,
reﬂecting a trend for a reduction in ﬁber size but unchanged nuclei
count when compared to wild type muscle (Fig. 3B). Both gas-
trocnemius and quadriceps muscle from nSod1KO mice showed
increased numbers of ﬁbers with central nuclei (Fig. 3C). This is in
agreement with our previous ﬁnding of an increased numbers of
central nuclei in gastrocnemius muscle from Sod1KO mice [2]. TheGastrocnemius
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and regeneration of quadriceps muscle ﬁbers in the nSod1KO mice
compared to wild type mice. Single muscle ﬁber size, force gen-
eration and the nuclei count vary between glycolytic and oxidative
ﬁbers and the changes described above can be inﬂuenced by the
change in muscle ﬁber type composition. However, as shown in
Fig. 3D, we do not report a ﬁber type transition between gastro-
cnemius and quadriceps muscles from wild type and nSod1KO
mice.
Changes in NMJ morphology and markers of denervation
One of the most robust changes we have reported in the
Sod1KO mice are changes in NMJ structure and function and a loss
of innervation [2,4,12]. These same changes occur with age in wild
type mice [11]. To determine whether a selective loss of neuronal
CuZnSOD can lead to alterations in NMJs and loss of innervation,Fiber diameter (μm)
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mice were used (wild type–black bars, nSod1KO–white bars).we examined AChR morphology using immunostaining and
quantiﬁed the changes in receptor endplate area. During aging,
muscle atrophy is associated with fragmentation of AChRs, chan-
ges in shape and a reduction in receptor endplate area and we also
observed these changes in muscle from the Sod1KO mice [11]. As
shown in Fig. 4A, we found a signiﬁcant reduction in endplate area
in both gastrocnemius and quadriceps muscle from nSod1KO mice
compared to age matched wild type mice but no evidence of
fragmentation. To determine if the nSod1KO mice showed changes
in innervation, we measured the induction of expression of acet-
ylcholine receptor alpha (AChRα) and two other markers known to
increase transiently in skeletal muscle following denervation, the
transcription factor, Runx1 and GADD45α (Fig. 4B). The transcripts
for these three genes were increased signiﬁcantly in the gastro-
cnemius muscle from both Sod1KO and nSod1KO mice compared
to wild type mice. We found similar increases in these genes in
quadriceps muscle from the nSod1KO mice (right panel in Fig. 4B).IIb IIx IIa I IIb IIx IIa
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Fig. 4. Acetylcholine receptor morphology and denervation associated markers in nSod1KO mice (A) Acetylcholine receptors from gastrocnemius (A–D) and quadriceps
muscles (E–H) (scale bar¼10 mm for receptors and 40 mm for clusters). (B) mRNA levels of the denervation markers. In gastrocnemius, npo0.001 nSod1KO vs wild type,
npo0.01 Sod1KO vs wild type for AChRα mRNA; npo0.01 nSod1KO vs wild type, npo0.0001 Sod1KO vs wild type for Runx1 mRNA; npo0.05 nSod1KO vs wild type,
npo0.001 Sod1KO vs wild type for GADD45αmRNA by analysis of variance (ANOVA) with comparisons between groups performed using Newman–Keuls post-hoc test using
Prism6 software. In quadriceps, npo0.01 nSod1KO vs wild type for AChRα mRNA; npo0.0001 nSod1KO vs wild type for Runx1 mRNA, npo0.05 nSod1KO vs wild type for
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K. Sataranatarajan et al. / Redox Biology 5 (2015) 140–148 145However, the expression of two additional genes associated with
the NMJ (MuSK and Rapsyn) whose expression is increased with
denervation, was not increased. These data suggest a morpholo-
gical change in the AChR consistent with changes seen in the
initiation of denervation; however, the NMJ fragmentation and
denervation that occurs in muscle from the Sod1KO mice is not
seen in the nSod1KO mice.
Changes in mitochondrial function and oxidative damage
One of the most robust alterations we have measured in
response to denervation is mitochondrial dysfunction, especially
an increase in generation of H2O2 by isolated muscle mitochondria
and increased oxidative damage. For example, we have reportedpm
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Using the ﬂuorescent probe Amplex Red, we measured H2O2
generation in mitochondria isolated from gastrocnemius of wild
type and 17–22 month old nSod1KO mice (Fig. 5A). H2O2 genera-
tion was not signiﬁcantly increased during State 1 respiration (no
exogenous substrate provided) or in response to glutamate and
malate as substrates in the gastrocnemius muscle of the nSod1KO
mice.
We have shown that the increased generation of ROS by
mitochondria in the Sod1KO mice and other mouse models of
denervation results in increased oxidative stress as measured by
oxidative damage [2,13]. To determine whether oxidative damage
is elevated in muscle from nSod1KO mice as we have previously0.00
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K. Sataranatarajan et al. / Redox Biology 5 (2015) 140–148146reported in muscle from Sod1KO mice [6], we measured
F2-isoprostane levels, a marker of lipid peroxidation, in quadriceps
muscle from wild type, Sod1KO and nSod1KO mice (Fig. 5B).
F2-isoprostanes were elevated more than 30% in quadriceps
muscle from Sod1KO mice compared to muscle from wild type
mice, but were not elevated in muscle from the nSod1KO mice. Our
previous studies show that loss of skeletal muscle mass in the
Sod1KO mice is associated with increased oxidative damage and
compensatory up-regulation of RONS regulatory enzymes [4,15].
To determine whether protein nitration is increased in muscle
from the nSod1KO mice, we measured the levels of protein nitra-
tion (Fig. 6A) and the protein content of PRXV (Fig. 6B), a perox-
ynitrite reductase. No signiﬁcant differences were observed in
gastrocnemius and quadriceps muscle between wild type and
nSod1KO mice. To further assess muscle redox changes, we mea-
sured the expression of RONS regulatory enzymes including
MnSOD, eNOS and iNOS (Fig. 7). Similar to our results on protein
nitration in the gastrocnemius, no signiﬁcant difference in
expression of RONS regulatory enzymes was detected in muscleWT
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cating no change in the overall redox status in muscle of nSod1KO
mice.Discussion
Aging is accompanied by a 30%–40% reduction in skeletal
muscle mass and function that is the main cause of frailty and loss
of independence in the elderly [16]. This phenomenon, called
sarcopenia, is universal to all mammalian species, and is observed
even in the absence of disease. The loss of muscle mass involves
both loss of muscle ﬁbers and, to a lesser extent, atrophy of the
remaining muscle ﬁbers. Aging in skeletal muscle is associated
with an increased number of ﬁbers per motor unit and ﬁber type
grouping consistent with a cycle of continual denervation and
reinnervation [17,18]. In addition to the changes that occur in
muscle tissue, parallel changes have also been reported in motor
neurons during aging that have been proposed to play anWT
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and alterations in axonal sprouting [19]. While the etiology of
sarcopenia is poorly understood, several potential contributing
factors have been identiﬁed, including loss of innervation, muscle
mitochondrial dysfunction, and oxidative stress [20,21].
Sod1KO mice, lacking CuZnSOD in all tissues, have elevated
levels of oxidative damage and a signiﬁcantly shortened lifespan
(30% reduction) compared to wild type mice [1,22]. The lifespan of
the Sod1KO mice can be restored to that of wild type mice by
dietary restriction [6]. In addition, many aging phenotypes are
accelerated in the Sod1KO mice, e.g., loss of hearing and hair,
thinning of skin, cataracts, and early onset of muscle atrophy
[1,22,23]. The accelerated loss of muscle in the Sod1KO mice is
similar in essentially every respect to the sarcopenia observed
with aging in wild type mice [24]. These similarities include an
age-dependent decrease in muscle mass (both absolute and rela-
tive to body mass) with the greatest decrease occurring in the
gastrocnemius, a muscle profoundly affected by aging in wild type
mice; a higher percentage of smaller muscle ﬁbers, evident even in
adult (8 month old) Sod1KO mice; and a failed adaptive response
[25]. The reduction in muscle mass is 30%–45% in hind limb in
Sod1KO mice by 20 months of age whereas wild type mice show
little change in hind limb muscle mass until after 26 months of age
[1]. The accelerated loss of muscle mass is associated with neu-
ronal changes, again, similar to those described in old wild type
mice. These include the loss of functional innervation [3] with
gross alterations in NMJ morphology, including reduced occu-
pancy of the motor endplates by axons, terminal sprouting, axon
thinning, and irregular swelling with reduced motor neuron
myelin thickness and ﬁber/axon diameter [1,12,26]. The decrease
in muscle mass and function and changes in neuronal structure
and function are prevented in both adult Sod1KO and old wild type
mice subjected to dietary restriction [6,11].
Using transgenic and knockout mouse models that con-
ditionally express CuZnSOD, we have begun to deﬁne the role that
muscle and motor neurons play in the accelerated loss of muscle
observed in the Sod1KO mice. Our previous studies showed that
(1) Sod1KO mice expressing CuZnSOD speciﬁcally in neuronal
tissue (nSOD1-Tg/Sod1KO mice) were protected from the muscle
atrophy and weakness as well as from the NMJ degeneration [4]
and (2) mSod1KO mice, in which Sod1 is deleted speciﬁcally in
skeletal muscle, showed no muscle atrophy or NMJ degeneration
[5]. Based on the observation that the loss of CuZnSOD in muscle
appeared to have very little effect on muscle atrophy, we proposed
that the accelerated sarcopenia phenotype we observed in the
Sod1KO mice occurred as a result of increased oxidative stress in
the motor neurons, which led to NMJ dysfunction/disaggregation
and the eventual loss of muscle mass and function. Thus, we
predicted that deletion of CuZnSOD in neuronal tissue (in the
nSod1KO mice) would recapitulate the sarcopenia phenotype
observed in the Sod1KO mice. However, our data show that the
mass of the gastrocnemius, which is the muscle showing the
greatest atrophy in Sod1KO and old wild type mice, was not
reduced in nSod1KO compared to wild type mice, even at
20 months of age. In addition, no reduction in mass of the tibialis
anterior and extensor digitorum longus muscles was observed in
the nSod1KO mice. At 20–25 months of age, the Sod1KO mice show
over a 50% decrease in the muscle mass of the gastrocnemius and
a 19–25% decrease in the mass of the tibialis anterior and extensor
digitorum longus muscles. We did observe a slight but signiﬁcant
decrease in the mass of the quadriceps and soleus muscles in the
nSod1KO mice, which was similar to the decrease observed in
Sod1KO mice. Interestingly, the data from the mSod1KO and
nSod1KO mice show that changes in muscle force generation and
muscle mass appear to occur through separate mechanisms
because muscle atrophy (quantity) and muscle weakness (quality)did not always parallel each other. For example, gastrocnemius
muscles of mSod1KO mice were weaker than those of wild type, as
indicated by lower values for speciﬁc force (normalized for muscle
cross-sectional area) even though the mass of the gastrocnemius
muscles of the mSod1KO mice was slightly larger (nearly a 15–20%
increase in mass relative to body weight in mSod1KO vs wild type
mice). In the present study, we observed that the gastrocnemius
and the extensor digitorum longus muscles from the nSod1KO
mice were also signiﬁcantly weaker than those of wild type mice
even though the masses of the muscles were not different
between the nSod1KO and wild type mice. On the other hand, the
soleus showed a decrease in muscle mass in the nSod1KO mice
and a concomitant decrease in absolute force, but speciﬁc force
was not different between nSod1KO and wild type mice, indicating
no qualitative change in the force generating capacity of the tissue.
In contrast to the mSod1KO mice, we found that the nSod1KO
mice at 17–22 months of age showed changes in NMJ morphology
(reduced endplate area) and increased expression of AChRα,
Runx1 and GADD45α, genes associated with denervation [2,27,28].
However, we did not observe any evidence of NMJ fragmentation
in the nSod1KO mice. In contrast, Sod1KO mice show evidence of
NMJ fragmentation as early as 5 months of age [11]. These results
suggest that deleting Sod1 in neuronal tissue has an effect on NMJ
structure/function; however, this effect is much less severe than
that which occurs in the Sod1KO mice. We have found the
induction of production of reactive oxygen species by isolated
muscle mitochondrial (mtROS, as measured by H2O2 generation)
and increased oxidative damage and stress in muscle to be con-
sistently associated with NMJ fragmentation and denervation. For
example, mtROS is induced over 30-fold following sciatic nerve
transection [13]. In addition, the level of mtROS production by
muscle is correlated with the severity of muscle atrophy, e.g.
mtROS increased approximately by 30% in 30-month-old wild type
mice, more than 50% in 20-month-old Sod1KO mice, and
approximately 75% in muscle from symptomatic amyotrophic
lateral sclerosis (ALS) mice [13] and dietary restriction dramati-
cally reduces muscle atrophy and mtROS generation in muscle of
the Sod1KO mice [11]. We did not observe any signiﬁcant change
in either mtROS generation, oxidative damage (measured by
F2-isoprostane or protein nitration levels), or oxidative stress
(measured by RONS regulatory enzymes) in the muscle of the
nSod1KO mice. Thus, the changes we observed in the NMJs of the
nSod1KO mice do not lead to changes in the muscle that we
observe in the Sod1KO mice.
Based on our data with the conditional knockout and trans-
genic mice, we propose that muscle atrophy in Sod1KO mice
occurs through a “two-hit”mechanism involving changes in motor
neurons and changes in muscle. We propose that the “ﬁrst hit”
occurs when redox homeostasis is compromised in motor neurons
resulting in alteration in NMJ morphology and function. The
“second hit” occurs when the muscle mitochondria are altered
(e.g., increased ROS production) in response to NMJ dysfunction
and the alteration in muscle mitochondria triggers a retrograde
response leading to increased NMJ damage, which in turn leads to
further dysfunction in NMJs and motor neurons. The increased
NMJ dysfunction leads to a further increase in muscle mitochon-
drial dysfunction, resulting in a vicious cycle that ultimately
results in NMJ fragmentation, denervation, loss of muscle ﬁbers,
and sarcopenia. Preventing the initial motor neuron defect, as in
the nSOD1-Tg/Sod1KO mouse, prevents the mitochondria dys-
function and increased oxidative damage/stress in muscle as well
as the cascade of events leading to sarcopenia even though the
antioxidant defense system in the muscle is compromised. The
mSod1KO mice, which show no NMJ fragmentation, mitochondria
dysfunction, or oxidative damage/stress support the “two-hit”
mechanism by showing that without the initial motor neuron
K. Sataranatarajan et al. / Redox Biology 5 (2015) 140–148148dysfunction there is no trigger to induce mitochondria dysfunction
in muscle mitochondria and therefore, no NMJ fragmentation,
again indicating that the dysfunction in motor neurons/NMJ is
necessary to initiate the mitochondria dysfunction in the muscle.
Finally, nSod1KO mice do not show muscle atrophy in most mus-
cles because the initial motor neuron dysfunction does not trigger
sufﬁcient mitochondrial dysfunction and oxidative damage/stress
in the muscle of the nSod1KO mice, which have an intact anti-
oxidant defense system. Therefore, the nSod1KO mice lack the
“second hit,” which would lead to the vicious cycle and increased
NMJ dysfunction and fragmentation.Acknowledgments
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